BioShield Bill Creates “Emergency Use Authority” Tied To Monetary Penalties

FDA could license bioterrorism countermeasures for "emergency use" with the legal backing of monetary penalties to ensure companies comply with the agency's terms under the Senate's "BioShield" bill